Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Greg C. G. Wei"'
Autor:
Josh Y.H. Chen, Greg C. G. Wei
Publikováno v:
Drug Information Journal. 39:139-148
Drugs that alter ventricular repolarization have been associated with malignant ventricular arrhythmia, which has been shown to increase with increasing QT interval-the time required for ventricular depolarization and repolarization. To determine whe
Publikováno v:
Journal of Clinical Pharmacology. 42:444-449
Atorvastatin is a common option among the HMG-CoA reductase inhibitors for the treatment of lipid disorders because of its excellent lipid-lowering efficacy and overall safety profile. Although these agents can rarely cause rhabdomyolysis by themselv
Publikováno v:
The Journal of Clinical Pharmacology. 39:842-846
This study was performed to examine the effect of the coadministration of azithromycin on the pharmacokinetics of the protease inhibitor indinavir (Crixivan®). In an open-label, parallel-design study, 32 healthy male and female volunteers were given
Autor:
Greg C. G. Wei
Publikováno v:
Journal of Biopharmaceutical Statistics. 8:103-114
The potency of a batch of drug product needs to meet a release limits at the time of release so that the potency at the end of shelf life remains above the lower registration limit (LRL). This article discusses two methods which determine the release
Autor:
Greg C. G. Wei
Publikováno v:
Drug Information Journal. 31:1237-1242
This paper proposes a simple procedure for selecting sampling time points and sample allocation which reduce the mean square error or area under the curve (AUC) approximated by the trapezoidal approximation. It can generate desirable time points and
Publikováno v:
Pharmaceutical Research. 13:168-172
Purpose. The purpose of this study was to investigate the percutaneous absorption of ketoprofen applied topically to different anatomical sites on the body.
Autor:
K. K. Midha, Robert O. Kringle, Fred C. Snikeris, Alexander W. Boddy, James A. Oppermann, Greg C. G. Wei
Publikováno v:
Pharmaceutical Research. 12:1865-1868
Purpose. Highly variable drugs pose a problem in bioequivalence assessment because they often fail to meet current regulatory acceptance criteria for average bioequivalence (80–125%). This paper examines alternative approaches to establishing bioeq
Autor:
Greg C. G. Wei
Publikováno v:
Encyclopedia of Biopharmaceutical Statistics ISBN: 1439822468
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dea8d4cf2f03bb3f3cb0abc95734714
https://doi.org/10.3109/9781439822463.181
https://doi.org/10.3109/9781439822463.181
Publikováno v:
Encyclopedia of Biopharmaceutical Statistics ISBN: 1439822468
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::413f3fd878201593d8b6d6087535dbba
https://doi.org/10.3109/9781439822463.163
https://doi.org/10.3109/9781439822463.163
Autor:
Robert J. Fountaine, Tina Checchio, Greg C. G. Wei, John G. Teeter, Rudolph Jaeger, Ashley Milton, David Albert Fryburg, Marilyn Stolar
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Active cigarette smoking is associated with increased permeability of the pulmonary alveolar epithelium, resulting in faster absorption of inhaled drugs such as Exubera® (EXU). Absorption of EXU is increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b1c2dbebff88b49b6081ff0ec624a64
https://europepmc.org/articles/PMC2485222/
https://europepmc.org/articles/PMC2485222/